The shares of America Movil S.A.B. de C.V. (NYSE:AMX) started off the last trading session with the price of $18.55 while closing the day with the price of $18.62. The shares of America Movil S.A.B. de C.V. (NYSE:AMX) Fell -0.37% with the Gain of 0.07 points.
The shares of America Movil S.A.B. de C.V. (NYSE:AMX) traded with the day volume of 1.34 Million shares whereas its average trading volume is 2.23 Million.
While analyzing the past performance of the stock we can see that the shares of America Movil S.A.B. de C.V. (NYSE:AMX) Loss -3.07% in the last week while Falling -0.43% in the last month. Past quarter performance shows the green light with 5.86%. The semi-annual and annual performance shows -1.12% and 41.7% respectively.
Some critical values of the shares of America Movil S.A.B. de C.V. (NYSE:AMX) to be discussed here are: the beta which shows the value at 0.53 while Average True Range of America Movil S.A.B. de C.V. (NYSE:AMX) demonstrate the value at 0.52. The weekly and monthly volatility of the shares of America Movil S.A.B. de C.V. (NYSE:AMX) are indicated at 2.52% and 2.94%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 50.96.
While studying the financial position of the shares of America Movil S.A.B. de C.V. (NYSE:AMX), we can see that the Market capitalization of the company is at 61.43 Billion. The shares outstanding for the company is 3.3 Billion and the shares float stands at 1.71 Billion. The income of the company stand at 1.56 Billion while the sales stand at 54.25 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.48, Price to Earnings or P/E is at 39.2, Price to Sales P/S show the value of 1.13, the Return on Asset ROA stood at 0.033 and the Return on Equity ROE depicted at 0.236 while Return on Investment ROI is at 0.107.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT)
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) started its previous trading session at $32.4 and closed at $34.07 showing a Rise of 3.87 Percent.
The Company traded with an average Volume of 793.79 Million whereas, its Day Volume stood at 1.34 Million.
Looking at the performance of the stock, Aimmune Therapeutics, Inc. (NASDAQ:AIMT) Gain 4.13% in the last week in its shares price and -3.24% in the last month. Quarterly performance shows a red of -5.18 Percent while Semi-Annual and Annual performances shows a 62.16 and 62.24 percent respectively.
Beta for Aimmune Therapeutics, Inc. (NASDAQ:AIMT) stands at 0 while the ATR (average true range) is at 2.31. The Stock’s Weekly and Monthly Volatility is 6.58% and 7.15% respectively showing a RSI value of 46.51.
While studying the financial position of the shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT), we can see that the Market capitalization of the company is at 1.67 Billion. The shares outstanding for the company is 48.97 Million and the shares float stands at 35.65 Million.
The Company generated an income of -104400000 and the sales of 0 in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.07 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 0 respectively.
The Return on Assets stands at -0.54, ROE shows a value of -0.59 and ROI for Aimmune Therapeutics, Inc. (NASDAQ:AIMT) is 0 as of Trailing Twelve Months period.
